Patent · US Active

Determining nucleic acid fragmentation status by coincident detection of two labeled probes

US7645581B2 · kind B2 · utility

107Cited by
29References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 4, 2007
Grant dateJan 12, 2010
Priority date
Expiry dateOct 4, 2027

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2021/6441
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods for determining nucleic acid fragmentation status are provided. A nucleic acid of interest in a reaction mixture is contacted with two or more different probes complementary to sites separated by a point of potential fragmentation. The probes each comprise a detectable marker. The nucleic acid of interest is flowed into a detection region, where two or more coincident detectable marker signals from the probes are detected. Fragmentation status of the nucleic acid of interest is determined, coincident detection of signals from two or more of the different probes indicating the nucleic acid of interest is not fragmented between the probes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.